window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : February 16, 2026

  • News
  • About Us
Contact Us

personalised medicine

  • Biotech,Cell & Gene Therapy,Clinical Development,Oncology,Precision medicine,Research & Development

    Inaphaea BioLabs boosts precision oncology with new partnerships, advanced tumour models, and digital patient avatars

    Inaphaea BioLabs, the translational contract research organisation (CRO) of ValiRx [...]

    September 26, 2025
  • Middle East,Technology and platforms,Women's Health

    Abu Dhabi Biobank expands access to cord blood banking through NMC Healthcare partnership

    Abu Dhabi Biobank has partnered with NMC Healthcare to expand [...]

    September 22, 2025
  • Cell & Gene Therapy,Pharmaceuticals and therapeutics,Technology and platforms

    Adva Biotechnology and Autolomous launch digital pioneer program for scalable autologous cell therapy manufacturing

    Adva Biotechnology Ltd. and Autolomous Ltd. have announced a strategic [...]

    September 7, 2025
  • CDMOs & Manufacturing,Cell & Gene Therapy,Patient Centricity,Technology and platforms

    Adva Biotechnology and Autolomous launch program to scale digital manufacturing of autologous cell therapies

    Adva Biotechnology and Autolomous have announced a collaboration to co-lead [...]

    August 27, 2025
  • Cell & Gene Therapy,Medical devices,Movers & Shakers,Partnerships & Funding,Pharmaceuticals and therapeutics,Technology and platforms

    Robots could slash cost of cell therapy by 74%, opening doors to wider access

    Multiply Labs and Universal Robots pioneer automated manufacturing for personalised [...]

    August 25, 2025
  • Drug Development,Global health,Patient Centricity,Research & Development

    Vitamin D shown to reduce liver damage by activating TXNIP gene, study finds

    New study shows how the vitamin D/TXNIP axis modulates ductular [...]

    July 28, 2025
  • Artificial Intelligence,Clinical Trials,Patient Centricity,Precision medicine,Technology and platforms

    Linus Health unveils AI-powered advances in early Alzheimer’s detection and personalized brain health at AAIC 2025

    Digital assessments designed to support earlier diagnosis, streamline Alzheimer’s trial [...]

    July 28, 2025
  • Artificial Intelligence,Oncology,Precision medicine

    Biostate AI expands RNA-based precision medicine with new partnerships across China, India and the US

    Global collaborations boost dataset powering AI diagnostics for cancer, cardiovascular [...]

    July 24, 2025
  • Biologics & Biosimilars,Drug Development,Oncology,Research & Development

    Why immunotherapy sometimes fails: Study reveals unintended effects of antibody design

    A new study from researchers in Japan has uncovered a [...]

    July 24, 2025
  • Artificial Intelligence,Market Access & Commercialization,Oncology

    Caris CMO on AI, equity, and the future of multi-omic oncology

    The former ASCO president shares his insights on breast cancer [...]

    July 4, 2025
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • IgniteData appoints Laura Hilty as CSO and Joe Lengfellner as CPO amid Series A funding close
    Categories: Clinical Development, Data Management, Digital Health, Movers & Shakers, Technology and platforms
  • Hans Schambye appointed as CEO of BOOST Pharma as BT‑101 advances toward Phase 3
    Categories: Biotech, Cell & Gene Therapy, Clinical Development, Movers & Shakers, Pharmaceuticals and therapeutics, Rare Diseases
  • SPT Labtech and BellBrook Labs unveil high-throughput screening platform targeting VPS4B in cancer research
    Categories: Biotech, Drug Development, Oncology, Research & Development, Technology and platforms
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top